These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 33307186)

  • 1. A population scale analysis of rare SNCA variation in the UK Biobank.
    Blauwendraat C; Makarious MB; Leonard HL; Bandres-Ciga S; Iwaki H; Nalls MA; Noyce AJ; Singleton AB
    Neurobiol Dis; 2021 Jan; 148():105182. PubMed ID: 33307186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic copy number gains of α-synuclein (SNCA) in Parkinson's disease and multiple system atrophy brains.
    Mokretar K; Pease D; Taanman JW; Soenmez A; Ejaz A; Lashley T; Ling H; Gentleman S; Houlden H; Holton JL; Schapira AHV; Nacheva E; Proukakis C
    Brain; 2018 Aug; 141(8):2419-2431. PubMed ID: 29917054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of somatic CNVs in brains of synucleinopathy cases using targeted SNCA analysis and single cell sequencing.
    Perez-Rodriguez D; Kalyva M; Leija-Salazar M; Lashley T; Tarabichi M; Chelban V; Gentleman S; Schottlaender L; Franklin H; Vasmatzis G; Houlden H; Schapira AHV; Warner TT; Holton JL; Jaunmuktane Z; Proukakis C
    Acta Neuropathol Commun; 2019 Dec; 7(1):219. PubMed ID: 31870437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutation.
    Kiely AP; Ling H; Asi YT; Kara E; Proukakis C; Schapira AH; Morris HR; Roberts HC; Lubbe S; Limousin P; Lewis PA; Lees AJ; Quinn N; Hardy J; Love S; Revesz T; Houlden H; Holton JL
    Mol Neurodegener; 2015 Aug; 10():41. PubMed ID: 26306801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of LRRK2 and SNCA in autosomal dominant Parkinson's disease in Turkey.
    Kessler C; Atasu B; Hanagasi H; Simón-Sánchez J; Hauser AK; Pak M; Bilgic B; Erginel-Unaltuna N; Gurvit H; Gasser T; Lohmann E
    Parkinsonism Relat Disord; 2018 Mar; 48():34-39. PubMed ID: 29248340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel A18T and pA29S substitutions in α-synuclein may be associated with sporadic Parkinson's disease.
    Hoffman-Zacharska D; Koziorowski D; Ross OA; Milewski M; Poznanski JA; Jurek M; Wszolek ZK; Soto-Ortolaza A; Awek JAS; Janik P; Jamrozik Z; Potulska-Chromik A; Jasinska-Myga B; Opala G; Krygowska-Wajs A; Czyzewski K; Dickson DW; Bal J; Friedman A
    Parkinsonism Relat Disord; 2013 Nov; 19(11):1057-1060. PubMed ID: 23916651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics of Synucleinopathies.
    Nussbaum RL
    Cold Spring Harb Perspect Med; 2018 Jun; 8(6):. PubMed ID: 28213435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SNCA variants and alpha-synuclein level in CD45+ blood cells in Parkinson's disease.
    Emelyanov A; Kulabukhova D; Garaeva L; Senkevich K; Verbitskaya E; Nikolaev M; Andoskin P; Kopytova A; Milyukhina I; Yakimovskii A; Timofeeva A; Prakhova L; Ilves A; Vlasova I; Pchelina S
    J Neurol Sci; 2018 Dec; 395():135-140. PubMed ID: 30316070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SNCA 3' UTR Genetic Variants in Patients with Parkinson's Disease.
    Blažeković A; Jerčić KG; Borovečki F
    Biomolecules; 2021 Nov; 11(12):. PubMed ID: 34944443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insufficient evidence for pathogenicity of SNCA His50Gln (H50Q) in Parkinson's disease.
    Blauwendraat C; Kia DA; Pihlstrøm L; Gan-Or Z; Lesage S; Gibbs JR; Ding J; Alcalay RN; Hassin-Baer S; Pittman AM; Brooks J; Edsall C; Chung SJ; Goldwurm S; Toft M; Schulte C; ; Hernandez D; Singleton AB; Nalls MA; Brice A; Scholz SW; Wood NW
    Neurobiol Aging; 2018 Apr; 64():159.e5-159.e8. PubMed ID: 29398121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α-Synuclein genetic variants predict faster motor symptom progression in idiopathic Parkinson disease.
    Ritz B; Rhodes SL; Bordelon Y; Bronstein J
    PLoS One; 2012; 7(5):e36199. PubMed ID: 22615757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Variants of SNCA Are Associated with Susceptibility to Parkinson's Disease but Not Amyotrophic Lateral Sclerosis or Multiple System Atrophy in a Chinese Population.
    Chen Y; Wei QQ; Ou R; Cao B; Chen X; Zhao B; Guo X; Yang Y; Chen K; Wu Y; Song W; Shang HF
    PLoS One; 2015; 10(7):e0133776. PubMed ID: 26208350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher vulnerability and stress sensitivity of neuronal precursor cells carrying an alpha-synuclein gene triplication.
    Flierl A; Oliveira LM; Falomir-Lockhart LJ; Mak SK; Hesley J; Soldner F; Arndt-Jovin DJ; Jaenisch R; Langston JW; Jovin TM; Schüle B
    PLoS One; 2014; 9(11):e112413. PubMed ID: 25390032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.
    Benitez BA; Davis AA; Jin SC; Ibanez L; Ortega-Cubero S; Pastor P; Choi J; Cooper B; Perlmutter JS; Cruchaga C
    Mol Neurodegener; 2016 Apr; 11():29. PubMed ID: 27094865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood RNA biomarkers in prodromal PARK4 and rapid eye movement sleep behavior disorder show role of complexin 1 loss for risk of Parkinson's disease.
    Lahut S; Gispert S; Ömür Ö; Depboylu C; Seidel K; Domínguez-Bautista JA; Brehm N; Tireli H; Hackmann K; Pirkevi C; Leube B; Ries V; Reim K; Brose N; den Dunnen WF; Johnson M; Wolf Z; Schindewolf M; Schrempf W; Reetz K; Young P; Vadasz D; Frangakis AS; Schröck E; Steinmetz H; Jendrach M; Rüb U; Başak AN; Oertel W; Auburger G
    Dis Model Mech; 2017 May; 10(5):619-631. PubMed ID: 28108469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variants and animal models in SNCA and Parkinson disease.
    Deng H; Yuan L
    Ageing Res Rev; 2014 May; 15():161-76. PubMed ID: 24768741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease.
    Nishioka K; Hayashi S; Farrer MJ; Singleton AB; Yoshino H; Imai H; Kitami T; Sato K; Kuroda R; Tomiyama H; Mizoguchi K; Murata M; Toda T; Imoto I; Inazawa J; Mizuno Y; Hattori N
    Ann Neurol; 2006 Feb; 59(2):298-309. PubMed ID: 16358335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new alpha-synuclein missense variant (Thr72Met) in two Turkish families with Parkinson's disease.
    Fevga C; Park Y; Lohmann E; Kievit AJ; Breedveld GJ; Ferraro F; de Boer L; van Minkelen R; Hanagasi H; Boon A; Wang W; Petsko GA; Hoang QQ; Emre M; Bonifati V
    Parkinsonism Relat Disord; 2021 Aug; 89():63-72. PubMed ID: 34229155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
    Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R
    Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SNCA 3'UTR genetic variants in patients with Parkinson's disease and REM sleep behavior disorder.
    Toffoli M; Dreussi E; Cecchin E; Valente M; Sanvilli N; Montico M; Gagno S; Garziera M; Polano M; Savarese M; Calandra-Buonaura G; Placidi F; Terzaghi M; Toffoli G; Gigli GL
    Neurol Sci; 2017 Jul; 38(7):1233-1240. PubMed ID: 28409245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.